ATOS ATOSSA THERAPEUTICS INC Management Changes 8-K Filing 2025 - Appointments On May 8, 2025, Atossa Therapeutics, Inc. held its Annual Meeting where stockholders elected directors, ratified Ernst & Young as auditors, and approved executive compensation, with key votes showing strong support for all proposals.Get access to all SEC 8-K filings of the ATOSSA THERAPEUTICS INC